Synthetic SARS-CoV-2 spike peptides

JA Jessica Andries
WV Wildriss Viranaicken
CC Colette Cordonin
CH Charline Herrscher
CP Cynthia Planesse
BR Bénédicte Roquebert
ML Marie Lagrange-Xelot
CE Chaker El-Kalamouni
OM Olivier Meilhac
PM Patrick Mavingui
DC David Couret
GG Gilles Gadea
PD Philippe Despres
request Request a Protocol
ask Ask a question
Favorite

All synthetic peptides used in this study were chemically synthesized by Genecust (Boynes, France). Peptides were dissolved in DMSO at concentration of 10 mg.mL−1 and then diluted in sterile H2O at the final concentration 1 mg.mL−1. The stock peptide solutions were stored at − 80 °C. Working peptide solutions at the final concentration 0.2 mg.mL−1 in sterile H2O were stored at − 80 °C.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A